September 1, 2023
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of a correction to Section III regarding the Foreign Institution Eligibility for RFA-NS-24-024 "Role of Environmental Stress in the Health Inequities of Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)". This notice of funding opportunity (NOFO) has been revised to show that Non-domestic (non-U.S.) Entities (Foreign Institutions) are NOT eligible to apply and Non-domestic (non-U.S.) components of U.S. Organizations are NOT eligible to apply. Foreign components are allowed as indicated in the original NOFO. Changes to the NOFO are shown below. This notice is effective for the November 1, 2023 due date.
Currently Reads:
1. Eligible Applicants
Eligible Organizations
Other
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
2. Content and Form of Application Submission
Foreign Institutions
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.
Modified to Read:
1. Eligible Applicants
Eligible Organizations
Other
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
2. Content and Form of Application Submission
Foreign Institutions
Not Applicable.
All other aspects of this NOFO remain unchanged.
David A. Jett, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-6035
Email: [email protected]